Analysis of K-ras, APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis

Gastroenterology

Volumn 121, Issue 3, 2001, Pages 599-611

  Takayama, Tetsuji ^a   Ohi, Motoh ^a   Hayashi, Tsuyoshi ^a   Miyanishi, Koji ^a   Nobuoka, Atsushi ^a   Nakajima, Takaharu ^a   Satoh, Tsutomu ^a   Takimoto, Rishu ^a   Kato, Junji ^a   Sakamaki, Sumio ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; FAMILIAL COLON POLYPOSIS; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0034830884     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.27203     Document Type: Article

References (50)

1. Genetic alterations during colorectal-tumor development
2. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer
3. A genetic model for colorectal tumorigenesis
4. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP)
5. Genetic changes and histological types in colorectal tumors from patients with familial adenomatous polyposis
6. APC mutations occur early during colorectal tumorigenesis
7. Inactivation of both APC alleles in an early stage of colon adenomas on a patient with familial adenomatous polyposis (FAP)
8. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings
9. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: Earliest recognizable precursor lesions of experimental colon cancer
10. Aberrant crypts: Putative preneoplastic foci in human colonic mucosa
11. Identification and quantification of aberrant crypt foci and microadenomas in the human colon
12. Aberrant crypt foci of the colon as precursors of adenoma and cancer
13. K-ras mutations in putative preneoplastic lesions in human colon
14. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons
15. Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue
16. Molecular determinants of dysplasia in colorectal lesions
17. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa
18. More frequent β-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP)-treated rats
19. Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis
20. Laser capture microdissection
21. Multiple K-ras codon 12 mutations in cholangio-carcinomas demonstrated with a sensitive polymerase chain reaction technique
22. Molecular diagnosis of familial adenomatous polyposis
23. β-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas
24. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
25. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors
26. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas
27. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin
28. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
29. Constitutive transcriptional activation by a b-catenin-Tcf complex in APC-/- colon carcinoma
30. Identification of dysplasia in human colonic aberrant crypt foci
31. Histology of aberrant crypt foci in the human colon
32. Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps
33. Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours
34. INK4a expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation
35. Evidence for genomic instability in human colonic aberrant crypt foci
36. Microsatellite instability in aberrant crypt foci from human colons
37. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice
38. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology
39. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis
40. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet
41. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats
42. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease
43. Aberrant crypt foci in human colons: Distribution and histomorphologic characteristics
44. Aberrant crypt foci in patients with colorectal cancer
45. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon
46. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation
47. The identification of monoclonality in human aberrant crypt foci
48. High frequency of K-ras mutations in sporadic colorectal adenomas
49. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas
50. Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors